|
Shandong Runxin Biotechnology Co.,Ltd
|
Shandong Runxin Biotechnology Co., Ltd is a global integrated contract manufacturer fo dietary supplement industry, providing wide range of products with different forms including softgel,tablet,capsule, granule and powder.
Runxin Biotechnology Located in Wucun Industrial Park, the Group’s production base covers a floor space of 20000 sq. meters with a total investment of 30 million yuan. Buttressed by D-level (100,000 level) GMP workshop, first-class production equipments of the State, highly productive R&D team and fully equipped testing center, the production base can ensure reliable product quality and meet customers’ requirements.We produce 80millions hard capsules,25millions soft capsules,50millions tablets, 120 tons powders, 134 tons granule per year. |
Send Inquiry
|
|
Sichuan Apothe Pharmaceuticals Ltd.
|
Diosmin is a flavonoid compound found in various plants, particularly in citrus fruits like oranges and lemons. It is commonly used as a dietary supplement and is known for its potential health benefits. Diosmin is primarily used for its venotonic and vasoprotective properties, meaning it helps improve blood circulation and strengthen blood vessels. It is often used to treat conditions related to poor blood flow, such as chronic venous insufficiency, varicose veins, and hemorrhoids. Diosmin can help reduce symptoms like leg swelling, pain, and heaviness in these conditions. Additionally, diosmin has anti-inflammatory and antioxidant effects. It can help reduce inflammation in the body and protect cells from damage caused by free radicals. These properties make it useful for managing conditions like arthritis and preventing oxidative stress. Diosmin is generally considered safe when taken as directed, although some people may experience mild side effects such as gastrointestinal discomfort or headache. It is important to consult with a healthcare professional before starting any new supplement to ensure it is appropriate for your individual needs and to avoid potential interactions with medications.
|
Send Inquiry
|
Pharma Sources Insight January 2025
